Published in Women's Health Weekly, May 15th, 2006
"A total of 125 postmenopausal pollen-allergic women (mean age: 61.26 yr) were split into four groups:
(1) treated with neither H1 histamine receptor (H1R) antagonist nor inhaled corticosteroid (n=43);
(2) treated only with H1R antagonist (n=53);
(3) treated with both H1R antagonist and inhaled corticosteroid (n=17);
(4) treated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly